Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Other · 26 Jul 2016 Review article · 26 Jul 2016 Novel mechanisms and new therapies for chronic obstructive pulmonary disease
There is a pressing requirement to develop new therapies for chronic obstructive pulmonary disease (COPD), as current therapies fail to prevent disease progression or mortality and do not deal with ... mainstay of…
Review article · 26 Jul 2016 Chronic obstructive pulmonary disease and lung cancer: inflammation, the missing link
link between chronic obstructive pulmonary disease (COPD) and lung cancer has been known for over 40 years. A total of 50–70% of patients diagnosed with lung cancer have COPD ... central to the pathogenesis of both COPD…
Review article · 26 Jul 2016 Women with chronic obstructive pulmonary disease: an emerging phenotype of the disease
western world, the bulk of the overall increase in chronic obstructive pulmonary disease (COPD)-related morbidity and mortality is driven in part by the increasing burden of disease in women
Perspective · 26 Jul 2016 Importance of integrated care for the chronic obstructive pulmonary disease patient
exacerbations is still the dominating approach in the management of chronic conditions such as chronic obstructive pulmonary disease (COPD). An acute care paradigm is no longer adequate for the changing
Other · 23 Jul 2016 Arformoterol: rationale for use in chronic obstructive pulmonary disease
Long-acting β-agonists (LABAs) are the standard of care for chronic obstructive pulmonary disease (COPD) patients with advanced disease, those with mild to moderate disease and frequent exacerbations
Other · 23 Jul 2016 Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Treating chronic obstructive pulmonary disease with long-acting bronchodilators improves lung function and patient-reported outcomes such as dyspnea, healthrelated quality of life and exacerbations. Combinations of…
Other · 23 Jul 2016 Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
muscarinic antagonist bronchodilator glycopyrronium (Seebri® Breezhaler® inhalation powder) in the GLOW (glycopyrronium bromide in chronic obstructive pulmonary disease airways) series of studies showed that, compared…
Editorial · 22 Jul 2016 Biomarkers in Chronic Obstructive Pulmonary Diseases
Review article · 22 Jul 2016 Long-term effects of inhaled bronchodilators in stable chronic obstructive pulmonary disease
chronic obstructive pulmonary disease (COPD) the inhaled bronchodilators represent the basis of the maintenance therapy, the therapeutic recommendations being made and adjusted based on the long-term therapeutic…
Other · 22 Jul 2016 Antibiotic treatment in exacerbations of chronic obstructive pulmonary disease: recent trial results
Exacerbations are the most frequent cause of hospitalization and death in patients with chronic obstructive pulmonary disease (COPD). In this review, the results of recent trials that have assessed
Perspective · 15 Jul 2016 Optimizing the management of chronic obstructive pulmonary disease: applying the GOLD strategy
goals for management of stable chronic obstructive pulmonary disease (COPD) as per the latest Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013 revision include reducing both symptoms (modified medical
Conference abstract · 14 Jul 2016 Early detection of chronic obstructive pulmonary disease in family practice
Introduction: In real practice Chronic Obstructive Pulmonary Diseases (COPD) is often diagnosed at a late stage as its clinical manifestations pass unnoticed and spirometry is almost not utilized. Objective
Conference abstract · 11 Jul 2016 Mechanisms of chronic obstructive pulmonary disease and airway smooth muscle remodeling: Potential roles of ABHD2
Chronic obstructive pulmonary disease (COPD) is a complex multifactorial illness involving both genetic and environmental factors and is one of the leading causes of death worldwide. Although considerable improvements…
Conference abstract · 11 Jul 2016 Chronic obstructive pulmonary disease complicating early-stage lung cancer
Chronic obstructive pulmonary disease (COPD) is present in 40-60% of Lung Cancer (LC) patients; some existed long before LC diagnosis and others were identifi ed at the time
Conference abstract · 11 Jul 2016 Chronic obstructive pulmonary disease: A study of the relationship between patients’ feeling of guilt due to their belief of the disease being self infl icted
Introduction: Chronic obstructive pulmonary disease (COPD) is an increasing health problem that aff ects about 600 million people globally and it is expected to be the third most common cause ... death worldwide by…
Conference abstract · 11 Jul 2016 Should we treat chronic obstructive pulmonary disease as a cardiovascular disease?
Chronic Obstructive Pulmonary Disease (COPD) is characterized by persistent airfl ow limitation that is usually progressive and is associated with an abnormal infl ammatory response in the lungs to noxious
Conference abstract · 11 Jul 2016 Genetic determinants of chronic obstructive pulmonary disease in south Indian male smokers
development of chronic obstructive pulmonary disease, upon exposure to tobacco smoke is the cumulative eff ect of defects in several genes. With the aim of understanding the genetic structure that
Conference abstract · 11 Jul 2016 Prophylactic vaccinations in chronic obstructive pulmonary disease
Patients with chronic obstructive pulmonary disease (COPD) are vulnerable to community-acquired respiratory infections such as infl uenza and Pneumonia. Th ese conditions may lead to an acute infective exacerbation
Conference abstract · 11 Jul 2016 Genetic Determinants of Chronic Obstructive Pulmonary Disease in South Indian Male Smokers
development of chronic obstructive pulmonary disease, upon exposure to tobacco smoke, is the cumulative effect of defects in several genes. With the aim of understanding the genetic structure that
Conference abstract · 11 Jul 2016 Chronic obstructive pulmonary disease: A study of the relationship between patients’ feeling of guilt due to their belief of the disease being self inflicted
Chronic obstructive pulmonary disease (COPD) is an increasing health problem that affects about 600 million people globally, and it is expected to be the third most common cause of death ... worldwide by 2020. COPD is a…
Conference abstract · 11 Jul 2016 Chronic obstructive pulmonary disease (COPD) complicating early-stage lung cancer (LC)
recorded medical diagnosis; severity was grouped by GOLD criteria (Global Initiative for Chronic Obstructive Lung Disease). Emphysema was based on standard-dose CT scan; percentage quantification was determined through…
Conference abstract · 11 Jul 2016 Mechanisms of Chronic obstructive pulmonary disease and airway smooth muscle remodeling: the potential roles of Abhd2
Chronic obstructive pulmonary disease(COPD)is a complex multifactorial illness involving both genetic and environmental factors and is one of the leading causes of death worldwide. Although considerable improvements have
Review article · 6 Jul 2016 Role of indacaterol in the management of asthma and chronic obstructive pulmonary disease
indacaterol administration may reach up to 300 ml in asthma and 200 ml in chronic obstructive pulmonary disease (COPD). This long-lasting stabilization of the airway caliber may potentially translate
Conference abstract · 16 Jun 2016 Upper extremity muscle volume and function as an indicator of pre-frailty in older adult patients with Chronic Obstructive Pulmonary Disease (COPD)
Background: In a survey of 2004 conducted by World Health Organization, chronic obstructive pulmonary disease (COPD) is proved third leading cause of death worldwide and develops frailty. However, the differences

